A detailed history of Fcg Investment CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Fcg Investment CO holds 2,791 shares of LLY stock, worth $2.14 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
2,791
Previous 2,757 1.23%
Holding current value
$2.14 Million
Previous $2.5 Billion 0.94%
% of portfolio
1.62%
Previous 1.89%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$772.14 - $960.02 $26,252 - $32,640
34 Added 1.23%
2,791 $2.47 Billion
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $155,847 - $195,443
215 Added 8.46%
2,757 $2.5 Billion
Q1 2024

Apr 19, 2024

SELL
$592.2 - $792.28 $129,691 - $173,509
-219 Reduced 7.93%
2,542 $1.98 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.45 Million - $1.71 Million
2,761 New
2,761 $1.61 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fcg Investment CO Portfolio

Follow Fcg Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcg Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Fcg Investment CO with notifications on news.